Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Buchanan

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Journal of Biomedical Materials Research|November 1, 1982
Susceptibility of surgical cobalt-base alloy to pitting corrosionL C Lucas, R A Buchanan, J E Lemons, et al.
Neurology|February 1, 1972
The metabolism of diphenylhydantoin (Dilantin) following once-daily administrationR A Buchanan, A W Kinkel, J R Goulet, et al.
Clinical Pharmacology and Therapeutics|February 1, 1976
Ethosuximide dosage regimensR A Buchanan, A W Kinkel, J L Turner, et al.
Clinical Pharmacology and Therapeutics|May 1, 1980
Plasma levels and urinary excretion of vidarabine after repeated dosingR A Buchanan, A W Kinkel, C A Alford, et al.
Clinical Toxicology|March 1, 1971
The effect of ultrasonic energy on the creatine phosphokinase determinationR A Buchanan, C E Moyer, J R Goulet, et al.
The Journal of Pediatrics|September 1, 1973
Single daily dose of diphenylhydantoin in childrenR A Buchanan, J L Turner, C E Moyer, et al.
Ultramicroscopy|February 1, 1993
Measurement of low calcium concentrations in cryosectioned cells by parallel-EELS mappingR D Leapman, J A Hunt, R A Buchanan, et al.
Annals of the New York Academy of Sciences|November 26, 1973
Effect of protein binding on the distribution of 5,5-diphenylhydantoin between plasma and red cellsP Borondy, W A Dill, T Chang, et al.
Journal of Clinical Pharmacology|April 29, 1998
Steady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizuresG M Kochak, J G Page, R A Buchanan, et al.
Journal of Biomedical Materials Research|July 1, 1981
Effects of carbon coupling on the in vitro corrosion of cast surgical cobalt-base alloyR A Buchanan, J E Lemons, C D Griffin, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Journal of Biomedical Materials Research|November 1, 1982
Susceptibility of surgical cobalt-base alloy to pitting corrosionL C Lucas, R A Buchanan, J E Lemons, et al.
Neurology|February 1, 1972
The metabolism of diphenylhydantoin (Dilantin) following once-daily administrationR A Buchanan, A W Kinkel, J R Goulet, et al.
Clinical Pharmacology and Therapeutics|February 1, 1976
Ethosuximide dosage regimensR A Buchanan, A W Kinkel, J L Turner, et al.
Clinical Pharmacology and Therapeutics|May 1, 1980
Plasma levels and urinary excretion of vidarabine after repeated dosingR A Buchanan, A W Kinkel, C A Alford, et al.
Clinical Toxicology|March 1, 1971
The effect of ultrasonic energy on the creatine phosphokinase determinationR A Buchanan, C E Moyer, J R Goulet, et al.
The Journal of Pediatrics|September 1, 1973
Single daily dose of diphenylhydantoin in childrenR A Buchanan, J L Turner, C E Moyer, et al.
Ultramicroscopy|February 1, 1993
Measurement of low calcium concentrations in cryosectioned cells by parallel-EELS mappingR D Leapman, J A Hunt, R A Buchanan, et al.
Annals of the New York Academy of Sciences|November 26, 1973
Effect of protein binding on the distribution of 5,5-diphenylhydantoin between plasma and red cellsP Borondy, W A Dill, T Chang, et al.
Journal of Clinical Pharmacology|April 29, 1998
Steady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizuresG M Kochak, J G Page, R A Buchanan, et al.
Journal of Biomedical Materials Research|July 1, 1981
Effects of carbon coupling on the in vitro corrosion of cast surgical cobalt-base alloyR A Buchanan, J E Lemons, C D Griffin, et al.
Pageof 6